Clinical trial

A Study of LY3439539 in Participants With Alzheimer's Disease

NCT07598370

Study summary

ClinicalTrials.gov

A Study of LY3439539 in Participants With Alzheimer's Disease

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention LY3439539 Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-05-21

PhasePHASE1

Conditions

Alzheimer Diseaseverified · MONDO: Alzheimer disease

Interventions

LY3439539DRUG

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Mapped research locations

OrlandoFlorida, United States2 Los AngelesCalifornia, United States1 Long BeachCalifornia, United States1 SingaporeSingapore1 OaklandCalifornia, United States1 IrvineCalifornia, United States1 Farmington HillsMichigan, United States1 MaitlandFlorida, United States1 ChristchurchNew Zealand1 MelbourneAustralia1 AdelaideAustralia1 KogarahAustralia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07598370 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.